Single-Dose Oxford–AstraZeneca COVID-19 Vaccine Followed by a 12-Week Booster
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Single-Dose Oxford–AstraZeneca COVID-19 Vaccine Followed by a 12-Week Booster
Lancet 2021 Mar 06;397(10277)854-855, IFN Hung, GA PolandFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.